Talk:Nav1.4

target for "atypical" muscle relaxant drugs?
Since this subtype of voltage-gated sodium channel occurs predominantly in skeletal muscle, wouldn't a subtype-selective reversible sodium channel blocker be a useful muscle relaxant? When I googled things like "selective Nav1.4 blocker" I didn't find anything except scientific papers on selective Nav1.7 blockers, which have completely different applications (potential medication against neuropathic pain and itch). --2003:E7:772C:6581:682A:2867:D228:31E6 (talk) 16:43, 13 October 2018 (UTC)